IP Library Granted Patent US 7,582,627
Granted Patent B2
US 7,582,627 · App. 11/452,121 · Granted Sep 1, 2009

3-aminoquinazolin-2,4-dione antibacterial agents

Assignee: Warner-Lambert Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,582,627
App. No.
11/452,121
Granted
Sep 1, 2009
Kind
B2
Abstract

Antibacterial 3-aminoquinazolin-2,4-diones have formula (I) wherein: R 1 and R 3 include alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclic, and heteroaryl; R 5 , R 6 , and R 8 include H, alkyl, alkoxy, halo, NO 2 , CN, NH 2 , alkyl and dialkylamino; R 7 includes hydrogen, alkyl, cycloalkyl, heterocyclic, fused heterocyclic, aryl and fused aryl; J and K are C or N; and pharmaceutically acceptable salts thereof.

Claims (80)

1. A compound of Formula VII

or pharmaceutically acceptable salt thereof,

wherein:

R 1 and R 3 independently are H,

C 1 -C 12 alkyl and substituted alkyl,

C 2 -C 12 alkenyl and substituted alkenyl,

C 2 -C 12 alkynyl and substituted alkynyl,

C 3 -C 12 cycloalkyl and substituted cycloalkyl,

aryl and substituted aryl,

heterocyclic and substituted heterocyclic,

or heteroaryl and substituted heteroaryl;

R 7 is hydrogen,

C 1 -C 12 alkyl and substituted alkyl,

C 2 -C 12 alkenyl and substituted alkenyl,

C 2 -C 12 alkynyl and substituted alkynyl,

halo,

NO 2 ,

CN,

NR′R″,

COOR′

aryl,

fused aryl,

heterocyclic,

fused heterocyclic,

bicyclic heterocyclic, or

spiro heterocyclic,

wherein all ring groups can be substituted; and

R 8 is H,

(O) n C 1 -C 12 alkyl and substituted alkyl,

(O) n C 2 -C 12 alkenyl and substituted alkenyl,

(O) n C 2 -C 12 alkynyl and substituted alkynyl,

wherein n is 0 or 1,

halo,

NO 2 ,

CN,

NR′R″;

wherein R′ and R″ independently are H,

C 1 -C 12 alkyl and substituted alkyl,

C 2 -C 12 alkenyl and substituted alkenyl,

C 2 -C 12 alkynyl and substituted alkynyl,

CO—C 1 -C 12 alkyl and substituted alkyl,

or R′ and R″ taken together with the nitrogen to which they are attached form a 3- to 7-membered ring containing from 1 to 3 heteroatoms selected from N, O, and S, said ring being unsubstituted or substituted with up to 4 substituent groups,

R 7 is hydrogen,

C 1 -C 12 alkyl and substituted alkyl,

C 2 -C 12 alkenyl and substituted alkenyl,

C 2 -C 12 alkynyl and substituted alkynyl,

halo,

NO 2 ,

CN,

NR′R″,

COOR′

aryl,

fused aryl,

heterocyclic,

fused heterocyclic,

bicyclic heterocyclic, or

spiro heterocyclic,

wherein all ring groups can be substituted.

2. A compound, or a pharmaceutically acceptable salt thereof, selected from the group consisting of:

3-Amino-7-[3-(1-aminoethyl)-4-fluoropyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-1-methylethyl)-4-fluoropyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-methoxyethyl)-4-fluoropyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[4-(1-amino-2-methoxyethyl)-3,3-dimethylpyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-phenoxyethyl)-pyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-phenoxyethyl)-4-methylpyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-phenoxyethyl)-4-fluoropyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-methoxyethyl)-4-fluoropyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[4-(1-amino-2-phenoxyethyl)-3,3-dimethylpyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-ethoxyethyl)pyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-ethoxyethyl)-4-methylpyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-ethoxyethyl)-4-fluoropyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-phenoxyethyl)-4,4-dimethylpyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-methoxypropyl)pyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-methoxyethyl)-4-methylpyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

3-Amino-7-[3-(1-amino-2-methoxypropyl)-4-fluoropyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione;

{2-Amino-2-[1-(3-amino-1-cyclopropyl-8-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[4,3-d]pyrimidin-7-yl)pyrrolidin-3-yl]ethylurea;

{2-Amino-2-[1-(3-amino-1-cyclopropyl-8-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[4,3-d]pyrimidin-7-yl)pyrrolidin-3-yl]ethylurea;

{2-Amino-2-[1-(3-amino-1-cyclopropyl-8-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[4,3-d]pyrimidin-7-yl)-4-methylpyrrolidin-3-yl]ethylurea;

{2-Amino-2-[1-(3-amino-1-cyclopropyl-8-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[4,3-d]pyrimidin-7-yl)-4-fluoropyrrolidin-3-yl]ethylurea; and

{2-Amino-2-[1-(3-amino-1-cyclopropyl-8-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[4,3-d]pyrimidin-7-yl)-4,4-dimethylpyrrolidin-3-yl]ethylurea.

Assignments (2)
CHANGE OF NAME Recorded Mar 28, 2013
From: PAH WLC LLC
To: ZOETIS WLC LLC
Reel/Frame 030120/0813 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2013
From: WARNER-LAMBERT COMPANY LLC
To: PAH WLC LLC
Reel/Frame 029896/0428 →
Continuity (4)
Division 1018222100
Provisional Application 6024126700 · Oct 18, 2000
Provisional Application 6017825200 · Jan 24, 2000
Related Publication 20060287308A1 · Dec 21, 2006